NovoTTF-100A: a new treatment modality for recurrent glioblastoma
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Neurology (clinical),General Neuroscience
Link
http://www.tandfonline.com/doi/pdf/10.1586/ern.12.80
Reference14 articles.
1. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
3. Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials
4. Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
5. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Experience about Chemoradiation treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Newly Diagnosed Glioblastoma (GBM) Patients in China;2024-05-08
2. Glioblastoma behavior study under different frequency electromagnetic field;iScience;2023-12
3. Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by TTFields;Cancers;2023-11-29
4. Chemoradiation treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM) in China;2023-11-01
5. Field Uniformity Optimization for Integrated Capacitance Sensing of Tumor Treating Field-Treated Cancer Cell Cultures;2023 IEEE 66th International Midwest Symposium on Circuits and Systems (MWSCAS);2023-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3